Fraser and Neave, Limited (SGX:F99)

Market Cap	2.02B
Revenue (ttm)	2.32B
Net Income (ttm)	146.11M
Shares Out	1.46B
EPS (ttm)	0.10
PE Ratio	13.88
Forward PE	n/a
Dividend	0.06 (3.96%)
Ex-Dividend Date	May 20, 2025

Volume	55,000
Average Volume	170,025
Open	1.390
Previous Close	1.400
Day's Range	1.380 - 1.400
52-Week Range	1.060 - 1.540
Beta	0.45
RSI	50.08
Earnings Date	Nov 11, 2025

About Blueprint Medicines

Fraser and Neave, Limited engages in the food and beverage, and publishing and printing businesses in Singapore, Malaysia, Thailand, Vietnam, and internationally. The company operates through Beverages, Dairies, Printing and Publishing, and Others segments. It produces and sells beverages, including 100PLUS isotonic drinks, F&N NUTRISOY soya milk, F&N SEASONS Asian drinks, F&N ICE MOUNTAIN drinking and sparkling water, as well as offers beer under CHANG brand. In addition, the company provides ice cream primarily under the F&N MAGNOLIA and F&N ...

• Industry: Dairy Products
• Founded: 1883
• Employees: 7,300
• Stock Exchange: Singapore Exchange
• Ticker Symbol: F99

Financial Performance

In 2024, Fraser and Neave's revenue was 2.16 billion, an increase of 3.00% compared to the previous year's 2.10 billion. Earnings were 150.91 million, an increase of 13.28%.